21 Urinary Bladder Cancer

Urinary Bladder Cancer

12

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II: Clinical Practice Version 1 - 21/04/2015

15. REFERENCES

22. Koning CCE, Blank LECM, Koedooder C, et al. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumours. Ann Oncol 2012;23:2948-2953. 23. van der Steen-Banasik EM, Ploeg M, Witjes JA, et al. Brachytherapy versus cystectomy in solitary bladder cancer: A case control, multicentre, East-Neth- erlands study. Radiother Oncol 2009;93:352-357. 24. van ‘t Riet A, Mak ACA, Moerland MA, et al. A conformation number to quan- tify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997;37:731-736. 25. Nap-van Klinken A, Bus SJEA, Janssen TG, et al. Interstitial brachythera- py for bladder cancer with the aid of laparoscopy. J Contemp Brachytherapy 2014;6:313-317. 26. ICRU. Dose and volume specifcation for reporting interstitial therapy, ICRU report, 58. Bethesda, MD: ICRU; 1997. 27. van der Steen-Banasik EM, Visser AG, Reinders JG, et al. From continuous LDR to office-hours PDR in bladder brachytherapy. Radiother Oncol 2007;83:S56. 28. van der Werf-Messing B. Carcinoma of the bladder treated by suprapubi- cradium implants. The value of additional external irradiation. Eur J cancer 1969;5:277-285. 29. Soete G, Coen V, Verellen D, et al. A feasibility of high dose rate brachytherapy in solitary urinary bladder cancer. Int J Radiat Oncol Biol Phys 1997;38:743-747. 30. Pos FJ, Horenblas S, Lebesque J, et al. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Int J Radiat Oncol Biol Phys 2004;59:696-705. 31. Bos M, Ordoñez Marmolejo R, Rasch CRN, et al. Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review. J Contemp Brachytherapy 2014;6:191-199. 32. Nieuwenhuijzen JA, Pos F, Moonen LM, et al. Survival after bladder-preserva- tion with brachytherapy versus radical cystectomy: a single institution experi- ence. Eur Urol 2005;48:239-245. 33. Aluwini S, van Rooij PH, Kirkels WJ, et al. Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results. Int J Radiat Oncol Biol Phys 2014;88:611- 617. 34. Kaufman DS, Winter KA, Shipley WU, et al. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral sur- gery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Urolo- gy 2009;73:833-837. 35. van der Steen-Banasik E, Smits G. Laparoscopic bladder implantations in solitary bladder cancer: Inevitable evolution? Int J Radiat Oncol Biol Phys 2013;87:S398. 36. de Crevoisier R, Ammor A, Court B, et al. Bladder-conserving surgery and in- terstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single insitution experience. Radiother Oncol 2004;72:147-157. 37. van Onna IEW, Oddens JR, Kok ET, et al. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tu- mours: results of 111 treated patients. Eur Urol 2009;56:113-122. 38. Pos F, Moonen L. Brachytherapy in the treatment of invasive bladder cancer. Semin Radiat Oncol 2005;15:49-54.

1. Babjuk M, Böhle A, Burger M, et al. Guidelines on non-muscle-invasive blad- der cancer (Ta, T1 and CIS). http://www.uroweb.org/gls/pdf/05 Non-muscle Invasive BC_TaT1_LR.pdf 2014. 2. Witjes JA, Compérat E, Cowan NC, et al. Guidelines on Muscle-invasive and metastatic bladder cancer. http://www.uroweb.org/gls/pdf/07 Muscle Invasive BC_LR LV2 May 14th.pdf 2014. 3. Coppin CM, Gospodarowicz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996;14:2901-2907. 4. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemother- apy in muscle-invasive bladder cancer. N Engl J Med 2012;366:1477-1488. 5. Dutch guidelines bladder carcinoma. http://www.oncoline.nl/bladdercarcino- ma 2013. 6. Pfister C, Roupert M, Neuzillet Y, et al. Recommandations en onco-urolo- gie 2013 du CCAFU: tumeurs de la vessie. Progrès en Urologie 2013;Suppl 2:S105-S125. 7. TNM classification of malignant tumours, 7th edition. Oxford: Wiley-Black- well; 2009. 8. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/Inter- national Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Con- ference Committee. Am J Surg Pathol 1998;22:1430-14311. 9. Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and peri- neural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 2003;169:955-960. 10. Tiki D, Reich O, Karakiewicz PI. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol 2010;58:112-117. 11. Ghoneim MA, Abdel-Latif M, el-Mekresh M. Radical cystectomy for carcino- ma of the bladder: 2720 consecutive cases 5 years later. J Urol 2008;180:121- 127. 12. Paik ML, Scolieri MJ, Brown SL, et al. Limitations of computerized tomog- raphy in staging invasive bladder cancer before radical cystectomy. J urol 2000;163:1693-1696. 13. NG CS. Radiologic diagnosis and staging of renal and bladder cancer. Semin Roentgenol 2006;41:121-138. 14. Blank LECM, Koedooder K, van Os R, et al. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and ex- ternal beam radiotherapy, for patients with solitary T1-T3 bladder tumours less than 5 cm in diameter. Int J Radiat Oncol Biol Phys 2007;69:454-458. 15. Battermann JJ, Tierie AH. Results of implantation for T1 and T2 bladder tu- mours. Radiother Oncol 1986;5:85-90. 16. Mazeron JJ, Crook J, Chopin D, et al. Conservative treatment of bladder carci- noma by partial cystectomy and interstitial iridium 192. Int J Radiat Oncol Biol Phys 1988;15:1323-1330. 17. Rozan R, E. A, Donnarieix D, et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 1992;24:469- 477. 18. van der Werf-Messing B, van Putten W. Carcinoma of the urinary bladder cate- gory T2,3NxM0 treated by 40Gy external irradiation followed by Caesium 137 implant at reduced dose (50%). Int J Radiat Oncol Biol Phys 1989;16:369-371. 19. van der Werf-Messing B, Menon RS, Hop WC. Carcinoma of the urinary blad- der category T2, T3 (NxM0) treated by the combination of radium implant and external irradiation: Second report. Int J Radiat Oncol Biol Phys 1983;9:481- 485. 20. van der Werf-Messing B, Menon RS, Hop WC. Carcinoma of the urinary blad- der category T3NxM0 treated by the combination of radium implant and ex- ternal irradiation: second report . Int J Radiat Oncol Biol Phys 1983;9:177-180. 21. van der Werf-Messing B, Hop WC. Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 1981;7:299-303.